BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CgA
123 results:

  • 1. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
    Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
    Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features and differential diagnosis of gastric metastases.
    Chen W; Liu C; Liu Y; Yuan J; Wang Z
    World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
    Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
    J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
    Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
    Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
    Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
    Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mixed adenoneuroendocrine carcinoma of the gallbladder.
    Wang Q; Li L; Li J; Fan W
    Rev Esp Enferm Dig; 2024 Jan; 116(1):48-49. PubMed ID: 37073699
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
    Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pro-Gastrin-Releasing Peptide as a Marker of Small Cell Lung cancer.
    Lyubimova NV; Kuz'minov AE; Markovich AA; Lebedeva AV; Timofeev YS; Stilidi IS; Kushlinskii NE
    Bull Exp Biol Med; 2022 Jun; 173(2):257-260. PubMed ID: 35737164
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
    Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
    Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma.
    Chen L; Hong W; Duan S; Li Y; Wang J; Zhu J
    Cancer Biol Ther; 2022 Dec; 23(1):281-293. PubMed ID: 35323086
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
    Ni J; Zhang X; Wang H; Si X; Xu Y; Zhao J; Chen M; Zhang L; Wang M
    Thorac Cancer; 2022 Feb; 13(4):539-548. PubMed ID: 34970848
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate.
    Chen L; Gnanasegaran G; Mandair D; Toumpanakis C; Caplin M; Navalkissoor S
    Endocr Relat Cancer; 2022 Jan; 29(2):111-120. PubMed ID: 34932018
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer.
    Almugbel FA; Timilshina N; Papadopoulos E; Al-Showbaki L; Alibhai SMH
    J Geriatr Oncol; 2022 Apr; 13(3):318-324. PubMed ID: 34924306
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Decaffeination and Neuraminidase Inhibitory Activity of Arabica Green Coffee (
    Muchtaridi M; Lestari D; Khairul Ikram NK; Gazzali AM; Hariono M; Wahab HA
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199752
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Feature Selection and Classification of Clinical Datasets Using Bioinspired Algorithms and Super Learner.
    Murugesan S; Bhuvaneswaran RS; Khanna Nehemiah H; Keerthana Sankari S; Nancy Jane Y
    Comput Math Methods Med; 2021; 2021():6662420. PubMed ID: 34055041
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
    Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
    Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis.
    Jiang Y; Nan H; Shi N; Hao W; Dong J; Chen H
    Mol Biol Rep; 2021 Mar; 48(3):2351-2364. PubMed ID: 33738723
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy.
    Loi M; Comito T; Franzese C; Desideri I; Dominici L; Lo Faro L; Clerici E; Franceschini D; Baldaccini D; Badalamenti M; Reggiori G; Lobefalo F; Scorsetti M
    J Geriatr Oncol; 2021 Sep; 12(7):1100-1103. PubMed ID: 33461945
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer.
    Almugbel FA; Timilshina N; AlQurini N; Loucks A; Jin R; Berger A; Romanovsky L; Puts M; Alibhai SMH
    J Geriatr Oncol; 2021 Jun; 12(5):786-792. PubMed ID: 33342723
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.